Markets.com Logo

XBIO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.858$
  • Previous Close
    2.8303$
  • 52 Week Change
    3.07$
  • Day Range
    0.03$
  • 52 Week High/Low
    2.2$ - 5.2683$
  • Dividend Per Share
    --
  • Market cap
    4 349 K$
  • EPS
    -0.45
  • Beta
    2.329
  • Volume
    --

About

XBIO.US represents the ticker symbol for the ProShares UltraShort Nasdaq Biotechnology ETF. This ETF is designed to deliver twice the inverse (opposite) of the daily performance of the Nasdaq Biotechnology Index. Therefore, it is a leveraged bearish investment vehicle that aims to profit from a decline in the value of biotechnology stocks included in the Nasdaq Biotechnology Index. Investors should understand that due to the leveraged nature of the fund and daily resetting, its performance over periods longer than one day may deviate significantly from the stated multiple of the underlying index's return and is not intended for buy-and-hold strategies.

The Hormuz Dilemma: Allies Face a Thorny Choice Over Oil Security and International Law

Noah Lee|--

Iran Conflict Fuels Oil Surge, Threatening US Growth and Inflation, Delaying Fed Rate Cuts

Liam James|--

Federal Reserve Holds Rates Steady, Dot Plot Signals Gradual Future Cuts Amid Economic Uncertainty

Emma Rose|--
Social media stock analysis: Why Meta Platforms (META) stock is falling today?

Social media stock analysis: Why Meta Platforms (META) stock is falling today?

Ghko B|--

Who Controls the Strait of Hormuz: The Decisive Battle in the US-Iran Conflict

Ava Grace|--

Meta's Latest Layoffs: Signal of Redundancy or AI Investment Returns?

Noah Lee|--

Senior US Official Resigns, Citing Israeli Pressure and False Threats as Motivation for Iran War

Liam James|--

Factors

Clinical Trial Results: Positive data from clinical trials typically drive the stock price higher, while negative or inconclusive results can lead to a decline.

Regulatory Approvals: FDA approval of XBIObio's products significantly boosts investor confidence and increases stock value.

Competition: The presence and success of competing therapies can negatively impact XBIO's market share and stock price.

Market Sentiment: Overall investor optimism or pessimism towards the biotechnology sector can influence XBIO's stock.

Financial Performance: Strong revenue growth and profitability can attract investors and raise the stock price.

People Also Watch

Latest news

US Strategic Petroleum Reserve Release: Market Impact and Trader Strategies

Sophia Claire|--

US-Israel Alliance: Tactical Alignment, Strategic Divergence in the Iran Conflict

Liam James|--

Bank of Japan Navigates Oil Price Surge, Likely to Hold Rates Steady

Liam James|--

Latest Education Articles

Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Ghko B|--
How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

Ghko B|--
Crypto trading for beginners: How to trade Bitcoin (BTC/USD) in UAE & Dubai?

Crypto trading for beginners: How to trade Bitcoin (BTC/USD) in UAE & Dubai?

Ghko B|--